Abstract

A method is reported for recognizing MCF-7 human breast carcinoma cells based on silica-encapsulated nanoparticles modified with aminophenylboronic acid which can recognize sialic acid on cell surfaces. Gold@rhodamine B nanoparticles were coated with aminophenylboronic acid and used to capture MCF-7 cells. It is found that the presence of gold NPs was favorable to prepare nanoparticles easily and that they were extraordinarily biocompatible with MCF-7 cells. The experimental results confirmed that the nanoparticles can be used to target breast carcinoma cells using HS 578Bst normal breast cells as the negative control. The MCF-7 cells were imaged by laser scanning microscopy and showed strong red fluorescence in dark field. An MTT test revealed an 82 % viability of cells when 50 mg · mL−1 fluorescent probe was used in the incubation experiments. The results exhibited that the NPs are innocuous and stable. In our perception, the method has a larege potential for early diagnosis of breast cancer due to high affinity between nanoparticles and the breast carcinoma cells.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.